The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


The demonstration of varying treatment effects among different subjects of patients is an important part of the analysis of clinical trials. But issues of censoring, truncation and inclusion criteria complicate the analysis of clinical trial data. Recent advances in proportional hazard methodologies provide regression diagnostics, improved point and interval estimates of the parameters of survival functions, handling of time dependent covariates in the analysis. This paper discusses the interactions between treatment and patient in the presence of censoring and to account heterogeneity using frailty model. The application of the frailty model with respect to pulmonary tuberculosis data are presented and discussed.

Keywords

Tuberculosis, Cox Proportional Hazard Model, Time-dependent Covariates, Gamma Shared Frailty Model
User